43 related articles for article (PubMed ID: 38716804)
1. Evaluating the utility of
Nakasone ES; Zemla TJ; Yu M; Lin SY; Ou FS; Carter K; Innocenti F; Saltz L; Grady WM; Cohen SA
Epigenetics; 2024 Dec; 19(1):2349980. PubMed ID: 38716804
[TBL] [Abstract][Full Text] [Related]
2. Molecular Pathology of Colorectal Cancer.
Harada S; Morlote D
Adv Anat Pathol; 2020 Jan; 27(1):20-26. PubMed ID: 31503031
[TBL] [Abstract][Full Text] [Related]
3. Biomarker-guided therapy for colorectal cancer: strength in complexity.
Sveen A; Kopetz S; Lothe RA
Nat Rev Clin Oncol; 2020 Jan; 17(1):11-32. PubMed ID: 31289352
[TBL] [Abstract][Full Text] [Related]
4. Re-assessing
Vedeld HM; Nesbakken A; Lothe RA; Lind GE
Clin Epigenetics; 2018; 10():70. PubMed ID: 29854011
[TBL] [Abstract][Full Text] [Related]
5. Methylation of ZNF331 is an independent prognostic marker of colorectal cancer and promotes colorectal cancer growth.
Wang Y; He T; Herman JG; Linghu E; Yang Y; Fuks F; Zhou F; Song L; Guo M
Clin Epigenetics; 2017; 9():115. PubMed ID: 29075358
[TBL] [Abstract][Full Text] [Related]
6. Molecular pathological classification of colorectal cancer.
Müller MF; Ibrahim AE; Arends MJ
Virchows Arch; 2016 Aug; 469(2):125-34. PubMed ID: 27325016
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of CpG Island Methylator Phenotype as a Biomarker in Colorectal Cancer Treated With Adjuvant Oxaliplatin.
Cohen SA; Wu C; Yu M; Gourgioti G; Wirtz R; Raptou G; Gkakou C; Kotoula V; Pentheroudakis G; Papaxoinis G; Karavasilis V; Pectasides D; Kalogeras KT; Fountzilas G; Grady WM
Clin Colorectal Cancer; 2016 Jun; 15(2):164-9. PubMed ID: 26702772
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic Alterations in Colorectal Cancer: Emerging Biomarkers.
Okugawa Y; Grady WM; Goel A
Gastroenterology; 2015 Oct; 149(5):1204-1225.e12. PubMed ID: 26216839
[TBL] [Abstract][Full Text] [Related]
9. Methylation of ZNF331 Promotes Cell Invasion and Migration in Human Esophageal Cancer.
Jiang S; Linghu E; Zhan Q; Han W; Guo M
Curr Protein Pept Sci; 2015; 16(4):322-8. PubMed ID: 25929867
[TBL] [Abstract][Full Text] [Related]
10. The novel colorectal cancer biomarkers CDO1, ZSCAN18 and ZNF331 are frequently methylated across gastrointestinal cancers.
Vedeld HM; Andresen K; Eilertsen IA; Nesbakken A; Seruca R; Gladhaug IP; Thiis-Evensen E; Rognum TO; Boberg KM; Lind GE
Int J Cancer; 2015 Feb; 136(4):844-53. PubMed ID: 24948044
[TBL] [Abstract][Full Text] [Related]
11. CpG island methylator phenotype is associated with response to adjuvant irinotecan-based therapy for stage III colon cancer.
Shiovitz S; Bertagnolli MM; Renfro LA; Nam E; Foster NR; Dzieciatkowski S; Luo Y; Lao VV; Monnat RJ; Emond MJ; Maizels N; Niedzwiecki D; Goldberg RM; Saltz LB; Venook A; Warren RS; Grady WM;
Gastroenterology; 2014 Sep; 147(3):637-45. PubMed ID: 24859205
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic inactivation of the BRCA1 interactor SRBC and resistance to oxaliplatin in colorectal cancer.
Moutinho C; Martinez-Cardús A; Santos C; Navarro-Pérez V; Martínez-Balibrea E; Musulen E; Carmona FJ; Sartore-Bianchi A; Cassingena A; Siena S; Elez E; Tabernero J; Salazar R; Abad A; Esteller M
J Natl Cancer Inst; 2014 Jan; 106(1):djt322. PubMed ID: 24273214
[TBL] [Abstract][Full Text] [Related]
13. Association of TP53 mutational status and gender with survival after adjuvant treatment for stage III colon cancer: results of CALGB 89803.
Warren RS; Atreya CE; Niedzwiecki D; Weinberg VK; Donner DB; Mayer RJ; Goldberg RM; Compton CC; Zuraek MB; Ye C; Saltz LB; Bertagnolli MM
Clin Cancer Res; 2013 Oct; 19(20):5777-87. PubMed ID: 23983256
[TBL] [Abstract][Full Text] [Related]
14. Epigenetics of colorectal cancer.
Goel A; Boland CR
Gastroenterology; 2012 Dec; 143(6):1442-1460.e1. PubMed ID: 23000599
[TBL] [Abstract][Full Text] [Related]
15. How many molecular subtypes? Implications of the unique tumor principle in personalized medicine.
Ogino S; Fuchs CS; Giovannucci E
Expert Rev Mol Diagn; 2012 Jul; 12(6):621-8. PubMed ID: 22845482
[TBL] [Abstract][Full Text] [Related]
16. Assessment of colorectal cancer molecular features along bowel subsites challenges the conception of distinct dichotomy of proximal versus distal colorectum.
Yamauchi M; Morikawa T; Kuchiba A; Imamura Y; Qian ZR; Nishihara R; Liao X; Waldron L; Hoshida Y; Huttenhower C; Chan AT; Giovannucci E; Fuchs C; Ogino S
Gut; 2012 Jun; 61(6):847-54. PubMed ID: 22427238
[TBL] [Abstract][Full Text] [Related]
17. Zinc-finger protein 331, a novel putative tumor suppressor, suppresses growth and invasiveness of gastric cancer.
Yu J; Liang QY; Wang J; Cheng Y; Wang S; Poon TC; Go MY; Tao Q; Chang Z; Sung JJ
Oncogene; 2013 Jan; 32(3):307-17. PubMed ID: 22370639
[TBL] [Abstract][Full Text] [Related]
18. TFAP2E-DKK4 and chemoresistance in colorectal cancer.
Ebert MP; Tänzer M; Balluff B; Burgermeister E; Kretzschmar AK; Hughes DJ; Tetzner R; Lofton-Day C; Rosenberg R; Reinacher-Schick AC; Schulmann K; Tannapfel A; Hofheinz R; Röcken C; Keller G; Langer R; Specht K; Porschen R; Stöhlmacher-Williams J; Schuster T; Ströbel P; Schmid RM
N Engl J Med; 2012 Jan; 366(1):44-53. PubMed ID: 22216841
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
